VITEK 2 Identification / Antimicrobial Susceptibility Test Cards 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 BioMérieux 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2017-04-24
  • 사례 출판 날짜
    2017-04-24
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: biomérieux vitek 2 identification / antimicrobial susceptibility test cards medical device manufacturer, biomérieux, has issued a medical device safety alert concerning its vitek 2 identification / antimicrobial susceptibility test cards. the manufacturer has identified a potential issue related to the white pouch which contains vitek 2 test cards for the product lots. the manufacturer has determined that the integrity of some of the vitek 2 test card pouches may be compromised. based on the investigation, a compromised test card pouch can impact card reagents due to the entry of moisture. the white pouch is composed of five layers of material, four of which are clear. all five layers must be compromised for a pouch to potentially allow moisture to enter the pouch. upon visual inspection of the pouch, user may notice a small puncture or tear in the packaging at the "stitch seal". per product labeling, do not use the card if the pouch (the white protective package cover) is damaged. based on internal testing, approximately 20% of card pouches exhibited a visual defect; the majority of card pouches with this visual defect maintained pouch integrity, i.E. at least one of the five material layers remained intact. however, 1 in 200 (0.5%) card pouches that passed careful visual inspection failed further integrity tests, indicating the potential for entry of moisture. studies by the manufacturer have demonstrated that a test card pouch defect can allow entry of moisture which can impact the test card reagents. moisture sensitivity can lead to antibiotic degradation (loss of potency). the anticipated consequence would be elevated mic results of some antimicrobials (leading to false-resistant results). the antimicrobial class most affected by moisture is the beta-lactam class. this includes penicillins, cephalosporins, and carbapenems. the most moisture-sensitive of the beta-lactams is imipenem. therefore, it is the best indicator of a pouch defect. two other moisture-sensitive antimicrobials are erythromycin and nitrofurantoin. one exception to the expected elevation in mics (or false resistance) that can occur due to the pouch defect is the esbl (extended-spectrum β-lactamase) test, which utilizes clavulanic acid in combination with three cephalosporins. clavulanic acid is also moisture sensitive, and if degraded, the esbl test could be falsely negative. the advanced expert system will determine presence of an esbl phenotype based on results of all beta lactams, including the esbl test. therefore, the impact of a false negative esbl test should be minimal. for vitek 2 identification cards, urea (ure) may be sensitive to moisture and a false positive reaction may occur. however, there is low risk of impact to identification result as the identification (id) algorithm generally allows two atypical reactions and will still provide a correct identification with a high degree of confidence. the knowledge bases are designed to account for both typical and atypical strains so an aberrant reaction should have low impact on identification results. the manufacturer advises users that it is not necessary to discard all cards from an impacted lot. users are recommending follow the instructions mentioned in fsn in the affected lots prior to use. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 24 april 2017.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: BioMérieux VITEK 2 Identification / Antimicrobial Susceptibility Test Cards
  • Manufacturer

Manufacturer